These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38229473)

  • 1. Remote assessment of the Penn computerised neurocognitive battery in individuals with 22q11.2 deletion syndrome.
    White LK; Hillman N; Ruparel K; Moore TM; Gallagher RS; McClellan EJ; Roalf DR; Scott JC; Calkins ME; McGinn DE; Giunta V; Tran O; Crowley TB; Zackai EH; Emanuel BS; McDonald-McGinn DM; Gur RE; Gur RC
    J Intellect Disabil Res; 2024 Apr; 68(4):369-376. PubMed ID: 38229473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
    Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct neurocognitive profiles and clinical phenotypes associated with copy number variation at the 22q11.2 locus.
    O'Hora KP; Kushan-Wells L; Schleifer CH; Cruz S; Hoftman GD; Jalbrzikowski M; Gur RE; Gur RC; Bearden CE
    Autism Res; 2023 Dec; 16(12):2247-2262. PubMed ID: 37997544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between intelligence quotient measures and computerized neurocognitive performance in 22q11.2 deletion syndrome.
    Gur RC; Moore TM; Weinberger R; Mekori-Domachevsky E; Gross R; Emanuel BS; Zackai EH; Moss E; Gallagher RS; McGinn DE; Crowley TB; McDonald-McGinn D; Gothelf D; Gur RE
    Brain Behav; 2021 Aug; 11(8):e2221. PubMed ID: 34213087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of psychiatric comorbidity and cognitive deficit on function in 22q11.2 deletion syndrome.
    Yi JJ; Calkins ME; Tang SX; Kohler CG; McDonald-McGinn DM; Zackai EH; Savitt AP; Bilker WB; Whinna DA; Souders MC; Emanuel BS; Gur RC; Gur RE
    J Clin Psychiatry; 2015 Oct; 76(10):e1262-70. PubMed ID: 26528648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
    Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
    Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musical auditory processing, cognition, and psychopathology in 22q11.2 deletion syndrome.
    Gao L; Tang SX; Yi JJ; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Calkins ME; Gur RE
    Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):765-773. PubMed ID: 30444066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities.
    Gur RE; Yi JJ; McDonald-McGinn DM; Tang SX; Calkins ME; Whinna D; Souders MC; Savitt A; Zackai EH; Moberg PJ; Emanuel BS; Gur RC
    Mol Psychiatry; 2014 Nov; 19(11):1205-11. PubMed ID: 24445907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts.
    Yi JJ; Weinberger R; Moore TM; Calkins ME; Guri Y; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RE; Gothelf D; Gur RC
    Brain Cogn; 2016 Jul; 106():33-41. PubMed ID: 27200494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Neurocognitive Profiles and Clinical Phenotypes Associated with Copy Number Variation at the 22q11.2 Locus.
    O'Hora KP; Kushan-Wells L; Hoftman GD; Jalbrzikowski M; Gur RC; Gur R; Bearden CE
    medRxiv; 2023 May; ():. PubMed ID: 37292882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes.
    Zarchi O; Diamond A; Weinberger R; Abbott D; Carmel M; Frisch A; Michaelovsky E; Gruber R; Green T; Weizman A; Gothelf D
    Eur Psychiatry; 2014 May; 29(4):203-10. PubMed ID: 24054518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
    Yirmiya ET; Mekori-Domachevsky E; Weinberger R; Taler M; Carmel M; Gothelf D
    Am J Med Genet A; 2020 Mar; 182(3):461-468. PubMed ID: 31837200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood cognitive development in 22q11.2 deletion syndrome: case-control study.
    Chawner SJRA; Doherty JL; Moss H; Niarchou M; Walters JTR; Owen MJ; van den Bree MBM
    Br J Psychiatry; 2017 Oct; 211(4):223-230. PubMed ID: 28882829
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurocognitive Profiles of 22q11.2 and 16p11.2 Deletions and Duplications.
    Gur R; Bearden C; Jacquemont S; Jizi K; Amelsvoort van T; van den Bree M; Vorstman J; Sebat J; Ruparel K; Gallagher R; Swillen A; McClellan E; White L; Crowley T; Giunta V; Kushan L; O'Hora K; Verbesselt J; Vandensande A; Vingerhoets C; van Haelst M; Hall J; Harwood J; Chawner S; Patel N; Palad K; Hong O; Guevara J; Martin CO; Bélanger AM; Scherer S; Bassett A; McDonald-McGinn D; Gur R
    Res Sq; 2023 Dec; ():. PubMed ID: 38234766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome.
    Nilsson SR; Fejgin K; Gastambide F; Vogt MA; Kent BA; Nielsen V; Nielsen J; Gass P; Robbins TW; Saksida LM; Stensbøl TB; Tricklebank MD; Didriksen M; Bussey TJ
    Cereb Cortex; 2016 Oct; 26(10):3991-4003. PubMed ID: 27507786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocognitive Functioning in Patients with 22q11.2 Deletion Syndrome: A Meta-Analytic Review.
    Moberg PJ; Richman MJ; Roalf DR; Morse CL; Graefe AC; Brennan L; Vickers K; Tsering W; Kamath V; Turetsky BI; Gur RC; Gur RE
    Behav Genet; 2018 Jul; 48(4):259-270. PubMed ID: 29922984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Neurocognition in Youth with CKD Using a Novel Computerized Neurocognitive Battery.
    Hartung EA; Kim JY; Laney N; Hooper SR; Radcliffe J; Port AM; Gur RC; Furth SL
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):39-46. PubMed ID: 26500247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
    Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
    Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions.
    Shashi V; Veerapandiyan A; Schoch K; Kwapil T; Keshavan M; Ip E; Hooper S
    J Intellect Disabil Res; 2012 Sep; 56(9):865-78. PubMed ID: 21883601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.